Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

TIMELAPSE

Financiado

TIMELAPSE. A VR application for speeding up time passage during chemotherapy

Chemotherapy can involve lengthy treatment sessions, lasting up to several hours. Such a duration, spent in an overly medicalized setting, can induce in the patients a monopolizing focus on their pathology, which leads to a substa... ver más

30/11/2025

UMIL

150K€

Presupuesto del proyecto: 150K€

Líder del proyecto

UNIVERSITA DEGLI STUDI DI MILANO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 3 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2024-02-12

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

ERC-2023-POC: ERC PROOF OF CONCEPT GRANTS

I+D

Cerrada hace 1 año

0% 100%

3 Participantes

UMIL

80.00K€ | Lider

UNIMIB

20.00K€ | Participante

KHORA APS

50.00K€ | Participante

Proyectos interesantes

FJC2021-047474-I Evaluación y tratamiento de trastornos mentales mediante Rea... 65K€ Cerrado

EMP-TU-2016-5294 Validación médica de un sistema de tratamiento de trastornos... 47K€ Cerrado

PSI Personified Self Interaction 150K€ Cerrado

RTI2018-100993-B-I00 MAXIMIZANDO LA EFICACIA Y LA VIABILIDAD DE LA TERAPIA DE EXP... 57K€ Cerrado

COMMUNICATE-HEAL-TH Communicate Heal th A Virtual Reality training tool for opt... 150K€ Cerrado

REALIDAD VIRTUAL Y METAVERSO EN LA TERAPIA GR... REALIDAD VIRTUAL Y METAVERSO EN LA TERAPIA GRUPAL E INDIVIDU... 213K€ Rechazado

Últimas noticias

27-11-2024: Videojuegos y creaci... Se abre la línea de ayuda pública: Ayudas para la promoción del sector del videojuego, del pódcast y otras formas de creación digital

27-11-2024: DGIPYME En las últimas 48 horas el Organismo DGIPYME ha otorgado 1 concesiones

27-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 2 concesiones

Duración del proyecto: 21 meses Fecha Inicio: 2024-02-12
Fecha Fin: 2025-11-30

Líder del proyecto

UNIVERSITA DEGLI STUDI DI MILANO

TRL 4-5

Presupuesto del proyecto 150K€

Descripción del proyecto Chemotherapy can involve lengthy treatment sessions, lasting up to several hours. Such a duration, spent in an overly medicalized setting, can induce in the patients a monopolizing focus on their pathology, which leads to a substantial decrease in their mental well-being. One way to alleviate the impact of long chemotherapy sessions would be accelerating subjective time passage as perceived by the patients, therefore making the treatment seemingly end more quickly. Stemming from the ERC Advanced Grant AN-ICON, the TIMELAPSE project proposes to prototype, test, and launch on the market a virtual reality (VR) application that will accelerate subjective time passage during chemotherapy. The idea, whose singular aspects were the object of previous scientific evidence, was so far not implemented comprehensively. TIMELAPSE will fill this R&D gap with unprecedented methods and targets, adopting a patient-centred approach to innovatively incorporate in the conception of the VR application the irreplaceable perspective of its end-users: the oncologic patients. TIMELAPSE will take this idea to proof of concept by means of five subsequent phases: 1. Theoretical elaboration, to shape a theoretical hypothesis concerning what types of VR content might accelerate subjective time passage during chemotherapy; 2. Participatory design, to refine this hypothesis by incorporating the users’ perspective; 3. Production, to develop the content for the VR application, to obtain a prototype ready to be tested. 4. Assessment, to demonstrate the tolerability and effectiveness of the VR application; and 5. Pre-commercialization, to prepare the launch of the VR application on the market. To ensure appropriate methodological tools for each phase, TIMELAPSE will rely on a collaboration between three actors: a core research group (part of the AN-ICON team); an industrial partner expert in VR applications (Khora); and a clinical partner with substantial expertise in cancer treatment (Fondazione IRCCS San Gerardo dei Tintori).

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores